- Presentations
- 2
- Markets
- 1
Baxdela is a brand of Delafloxacin marketed by Melinta Therapeutics, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Delafloxacin
- Brand owner
- Melinta Therapeutics
- Registered in
- United States
- Strengths and forms
- 300 mg/10.5 mL powder for injection, 450 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Baxdela 300 mg/10.5 mL powder for injectionIntravenous | Melinta Therapeutics | US FDA | Available on request |
| Baxdela 450 mg tabletOral | Melinta Therapeutics | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Baxdela
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.